EN
HI
Summary
As of 3 Nov, 2026, Krebs Biochemicals & Industries stock price is ₹54.52. During the trading session, the stock has moved between an intraday low of ₹53.40 and an intraday high of ₹57.69. Over the last 52 weeks, Krebs Biochemicals & Industries has traded between ₹38.33 and ₹76.85.
The stock has recorded a trading volume of 28,457 shares,. Its Average Traded Price (ATP) is ₹54.67, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 16 @ ₹54.52.
Krebs Biochemicals & Industries has an upper circuit limit of ₹67.92 and a lower circuit limit of ₹45.28. The total value traded stands at ₹15.56 L, and the delivery percentage for the day is 60.11%.
The stock is currently traded with a market lot size of 1. Krebs Biochemicals & Industries also offers a dividend yield of 0%.
Krebs Biochemicals & Industries Share Price Chart
Krebs Biochemicals & Industries Share Key Metrics
Volume
28457.00
Market Cap
117.55 CR
LTQ@LTP
16@54.52
ATP
54.67
Var Margin
100 %
Circuit Range
45.28-67.92
Delivery %
60.11 %
Value
15.56 L
ASM/GSM
No
Market Lot
1
Krebs Biochemicals & Industries Resistance and Support
Pivot 57.14
Resistance
First Resistance
57.95
Second Resistance
59.3
Third Resistance
60.11
Support
First Support
55.79
Second Support
54.98
Third Support
53.63
Krebs Biochemicals & Industries Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Nov 02 2026 | 56.61 | 54.52 | -3.66% | 57.69 | 53.4 |
| Fri Oct 30 2026 | 56.59 | 56.59 | -2.31% | 58.49 | 56.33 |
| Thu Oct 29 2026 | 59.95 | 57.93 | -2.06% | 61.77 | 56.84 |
Krebs Biochemicals & Industries Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-29 | Quarterly Results |
| 2026-08-06 | Quarterly Results |
| 2026-02-09 | Quarterly Results & Others |
| 2025-11-04 | Quarterly Results |
| 2025-05-20 | Audited Results |
Krebs Biochemicals & Industries News
Krebs Biochemicals & Industries Ltd-$ - 524518 - Board Meeting Intimation for Intimation For Board Meeting To Be Held On 29.10.2026.
Krebs Biochemicals board will meet on 29 Oct 2026 to approve financial results. The results will cover the quarter and half-year ended 30 September 2026.
Oct 16 2026 13:23:47
Krebs Biochemicals & Industries Management
| Name | Position |
|---|---|
| Rakesh Kalbate | Company Secretary & Compliance Officer |
| R T Ravi | Chairman |
Krebs Biochemicals & Industries Similar Stocks
Krebs Biochemicals & Industries FAQs
The Buying Price of Krebs Biochemicals & Industries share is 54.52 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Krebs Biochemicals & Industries stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Krebs Biochemicals & Industries, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Krebs Biochemicals & Industries shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Krebs Biochemicals & Industries shares is 0. Useful to assess the stock's value relative to its book value.
To assess Krebs Biochemicals & Industries’s valuation compare Sector P/E, P/B which are 39.15 & 3.23 with sector averages, along with growth rates and financial metrics.
The Market Cap of Krebs Biochemicals & Industries is 117.55 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Krebs Biochemicals & Industries share price is 76.85 & 38.33. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Krebs Biochemicals & Industries belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in KREBSBIO
